Journal of Medicinal Chemistry p. 1735 - 1746 (1992)
Update date:2022-08-04
Topics:
Boyd
Fung
Baker
Mantei
Armiger
Stein
Cohen
Egan
Barlow
Klinghofer
Verburg
Martin
Young
Polakowski
Hoffman
Garren
Perun
Kleinert
We describe the development of a series of soluble, potent, and bioavailable nonpeptide renin inhibitors. These inhibitors derived from a series of novel nonpeptide renin inhibitors which were recently identified in our laboratories, by alteration of the nature of the C-terminus (P2') of the molecules. Introduction of basic substituents into modified hydroxyethylene dipeptide isosteres gave inhibitors with improved solubility as well as improved potency against human plasma renin. In addition, these modifications produced inhibitors which displayed markedly improved intraduodenal bioavailability in both the ferret and cynomolgus monkey. We also present data which demonstrate excellent efficacy in the monkey for A-74273 (65), with an intraduodenal bioavailability of 16 ± 4% in the monkey, compared to 1.7 ± 0.5% for the dipeptide renin inhibitor enalkiren (A-64662, 75). A- 74273 is an example of a nonpeptide inhibitor which possesses a good balance of the desirable properties of potency, solubility, and lipophilicity and which is well absorbed into the intestine.
View MoreContact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Kaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Contact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
ZHEJIANG JIANYE CHEMICAL CO.,LTD.
Contact:86-571-64149273,64149234
Address:No. 48, Fuxi Road, Meicheng Town
Doi:10.1016/S0040-4020(01)88729-9
(1992)Doi:10.1021/op900193v
(2010)Doi:10.1016/S0040-4039(00)91893-8
(1992)Doi:10.1016/j.tet.2009.09.027
(2009)Doi:10.1246/bcsj.33.1468
(1960)Doi:10.1021/ol8006919
(2008)